In our analytical sample, SHBG <33.4 nmol/L has good accuracy, sensitivity and specificity, and it is capable of identifying higher risk of NAFLD, either in a population of young women predisposed to metabolic impairment or in young-adult/middle-aged women consulting for female sexual dysfunction. This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.